Is Johnson & Johnson Underperforming the S&P 500?

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various healthcare products for the consumer, pharmaceutical, and medical devices and diagnostics markets. With a market cap of $397.1 billion, the company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment.

Companies worth $200 billion or more are generally described as “mega-cap stocks,” and JNJ definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the general drug manufacturers industry. By focusing on developing innovative medicines and medical technologies, the healthcare giant solidifies its role as a leader in innovation.